Pharma news
Americas
Bernard Tyson was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 25 July 2018
Americas
The Patent Trial and Appeal Board has rejected another challenge to a Gilead-owned patent covering the company’s hepatitis C medicines. 24 July 2018
Americas
The US Court of Appeals for the Federal Circuit’s ruling that tribal sovereign immunity doesn’t apply in inter partes review proceedings has sparked questions over state protections at the Patent Trial and Appeal Board. 24 July 2018
Pharma
The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency. 23 July 2018
Americas
Allergan and the Saint Regis Mohawk Tribe suffered a blow today as the US Court of Appeals for the Federal Circuit affirmed a decision rejecting use of tribal sovereign immunity in the inter partes review. 20 July 2018
Americas
Greenberg Traurig announced on Monday, July 16, that it has added Brian Rubenstein as a shareholder in its Philadelphia office. 20 July 2018
Americas
Raymond Chen and Kathleen O’Malley were selected in the LSIPR 50 2018 publication for their influence on the life sciences industry. They featured in the government and policy section, as LSIPR reports. 20 July 2018
Americas
Sanofi has partnered with biotechnology company Revolution Medicines to develop treatments for multiple cancers. 19 July 2018
Americas
Ropes & Gray has added Charlotte Jacobsen from Fitzpatrick, Cella, Harper & Scinto as a partner in the firm’s life sciences IP litigation practice. 19 July 2018
Americas
In the area of precision medicine, there are questions surrounding what data is needed, how it is used, what it should look like and what concerns there are for patients and society, as Daniel Lim of Kirkland & Ellis reports. 17 July 2018